MedPath

广东立国制药有限公司

Ownership
-
Established
1999-05-05
Employees
-
Market Cap
-
Website
http://www.titanpharm.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Cefathiamidine

Product Name
头孢硫脒
Approval Number
国药准字H20066896
Approval Date
Jan 25, 2022
NMPA

Cefepime Hydrochloride

Product Name
盐酸头孢吡肟
Approval Number
国药准字H20052617
Approval Date
Jun 1, 2021
NMPA

Cefpirome Sulfate

Product Name
硫酸头孢匹罗
Approval Number
国药准字H20060365
Approval Date
May 11, 2021
NMPA

Cefminox Sodium

Product Name
头孢米诺钠
Approval Number
国药准字H20043141
Approval Date
Aug 5, 2020
NMPA

Cefixime

Product Name
头孢克肟
Approval Number
国药准字H20020587
Approval Date
Aug 5, 2020
NMPA

Cefuroxime Axetil

Product Name
头孢呋辛酯
Approval Number
国药准字H20000399
Approval Date
Aug 5, 2020
NMPA

Cefuroxime Sodium

Product Name
头孢呋辛钠
Approval Number
国药准字H19990003
Approval Date
Aug 4, 2020
NMPA

Cefonicid Sodium

Product Name
头孢尼西钠
Approval Number
国药准字H20056369
Approval Date
Aug 4, 2020
NMPA

Ceftezole Sodium

Product Name
头孢替唑钠
Approval Number
国药准字H20093054
Approval Date
Sep 24, 2019
NMPA

Terbinafine Hydrochloride

Product Name
盐酸特比萘芬
Approval Number
国药准字H20084456
Approval Date
Sep 17, 2018
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.